Coya Therapeutics
Open
$4.79
Prev. Close
$4.79
High
$4.79
Low
$4.73
Market Snapshot
$111.19M
-5.3
-1.07
$3.69M
8
The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29.
The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29.
Recently from Cashu
Coya Therapeutics Innovates Treg-Enhancing Biologics for Neurodegenerative Disease Treatment
Coya Therapeutics Focuses on Innovative Treg-Enhancing Biologics Coya Therapeutics, Inc., a Houston-based biotechnology firm, is at the forefront of developing biologics that enhance regulatory T cell…
Coya Therapeutics Focuses on Treg Biologics for Neurodegenerative Disease Treatment Advancements
Coya Therapeutics Enhances Focus on Treg-based Biologics for Neurodegenerative Diseases Coya Therapeutics, Inc., a Houston-based biotechnology company, is making significant strides in the development…
Coya Therapeutics Advances COYA 303: Innovative Therapy for Inflammatory Diseases
Coya Therapeutics Advances Innovative Immunomodulatory Therapy COYA 303 Coya Therapeutics, Inc., a Houston-based clinical-stage biotechnology company, is making significant strides in its investigatio…
Coya Therapeutics Advances COYA 303: Innovative Treatment for Inflammatory Diseases in Development
Coya Therapeutics Advances COYA 303: A Promising Therapeutic for Inflammatory Diseases Coya Therapeutics, Inc., a Houston-based clinical-stage biotechnology company, is making strides in the developme…